Muscular Dystrophy Association Research Grant for the HEALEY ALS Platform Trial
MDA Awards $500,000 Grant to Accelerate ALS Research Through the HEALEY ALS Platform Trial at Massachusetts General Hospital
September 19, 2024 09:00 ET | Muscular Dystrophy Association
New York, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) is proud to announce a new clinical research grant of $500,000 over three years, awarded to Sabrina Paganoni,...
Athira Pharma Logo RGB_300ppi.jpg
Athira Pharma to Focus on Advancement of ATH-1105 for the Treatment of Neurodegenerative Diseases
September 17, 2024 09:00 ET | Athira Pharma, Inc.
ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion expected by year end 2024 and commencement of dosing of...
Poltreg_logo_kolor.jpg
PolTREG Treg cell therapy for patients with type-1 diabetes shows long-term clinical remission and insulin independence
September 09, 2024 01:00 ET | PolTREG S.A.
PTG-007 cell therapy resulted in clinical remission in some patients for up to 12 yearsA proportion of patients remained insulin-independent for up to 24 monthsPTG-007 ready to enter pivotal studyData...
Actimed.png
Actimed Therapeutics Announces US FDA Grant of Orphan Drug Designation to S-oxprenolol (ACM-002) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
September 04, 2024 03:00 ET | Actimed Therapeutics
London, UK – 4th September 2024. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and...
harnesstx-logo.png
Harness Therapeutics Appoints Experienced R&D Executive and Physician-Scientist, Dr Paulo Fontoura, as Non-Executive Director
September 04, 2024 03:00 ET | Harness Therapeutics
Dr Paulo Fontoura brings 20 years’ experience of working in the pharma industry, with the most recent 16 years focusing on translational medicine and clinical development approaches for one of the...
logo_fitness-world-01.png
Fitness World Canada Partners with Augie’s Quest in the Mission to Cure ALS
September 03, 2024 11:03 ET | Fitness World
VANCOUVER, British Columbia, Sept. 03, 2024 (GLOBE NEWSWIRE) -- This September, Fitness World Canada joins forces with Augie’s Quest, an organization dedicated to finding a cure for ALS (Amyotrophic...
Unknown
EverythingALS Launches New Mobile App: A Comprehensive Research and Life Navigation Tool for the ALS Community
August 26, 2024 09:00 ET | EverythingALS
EverythingALS is proud to announce the launch of its new mobile app, now available on both the iOS and Android marketplaces.
MDA's #30DaysOfStrength Campaign for Muscular Dystrophy Awareness Month in September
MDA Kicks Off Muscular Dystrophy Awareness Month in September with ‘30 Days of Strength’ Campaign with Hundreds of Events to Advance Research and Care for the Neuromuscular Disease Community
August 26, 2024 08:58 ET | Muscular Dystrophy Association
New York, Aug. 26, 2024 (GLOBE NEWSWIRE) -- September marks the kick-off of the Muscular Dystrophy Association (MDA) ‘National Muscular Dystrophy Awareness Month’ to raise awareness and critical...
FullLogo_Transparent_NoBuffer.png
Project Mosaic Launches to Bring “Biopsies” to ALS Drug Development
August 21, 2024 13:10 ET | Project Mosaic
Project Mosaic is proud to announce the launch of a groundbreaking initiative aimed at revolutionizing ALS drug development.
IAFF Fill the Boot Labor Day Weekend
Muscular Dystrophy Association International Association of Fire Fighters Launch 420 Fill the Boot Fundraisers in Cities Across America Labor Day Weekend for the Muscular Dystrophy Association
August 19, 2024 09:15 ET | Muscular Dystrophy Association
New York, Aug. 19, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) in partnership with the International Association of Fire Fighters (IAFF) kick off more than 420 Fill the Boot...